Bristol-Myers Squibb
Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About BMY
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies.
BMY Key Statistics
Stock Snapshot
Bristol-Myers Squibb(BMY) stock is priced at $65.81, giving the company a market capitalization of 134.93B. It carries a P/E multiple of 14.42 and pays a dividend yield of 3.83%.
During the trading session on 2026-08-05, Bristol-Myers Squibb(BMY) shares reached a daily high of $66.31 and a low of $63.87. At a current price of $65.81, the stock is +3.0% higher than the low and still -0.7% under the high.
Trading activity shows a volume of 23.29M, compared to an average daily volume of 15.14M.
The stock's 52-week range extends from a low of $42.52 to a high of $68.10.
The stock's 52-week range extends from a low of $42.52 to a high of $68.10.
BMY News
AstraZeneca's (AZN) deal talks with Bristol-Myers Squibb (BMY) remain active, according to a Semafor report on Tuesday. Shares of Bristol-Myers edged higher by...
...
Biotech and Pharma Feature AstraZeneca-Bristol Myers: The Floodgates for Biotech Mergers Are Open In this article BMY 524715 LLY AZN ABBV Bristol Myers Squibb a...
Analyst ratings
65%
of 31 ratingsMore BMY News
Bristol-Myers Squibb Company (BMY) announced an update on their ongoing clinical study. Unlock powerful investing tools with TipRanks Premium to make smarter,...
A potential AstraZeneca (AZN) acquisition of Bristol-Myers Squibb (BMY) is unlikely to happen now after a report that the pharma giants have held deal talks, ac...
“Odd” is the word analysts are using to describe a potential Bristol-Myers Squibb tie-up with AstraZeneca. AstraZeneca shares were slumping while Bristol Myers...
Bank of America Securities analyst Jason Gerberry reiterated a Buy rating on Bristol-Myers Squibb yesterday and set a price target of $71.00. Claim 55% Off TipR...
AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX ADP SBUX MRNA AAPL TSLA AMZN META AMD NVDA PEP COST ADBE GOOG AMGN HON INTC INTU NFLX AD...
Not for the first time this year, Bristol Myers Squibb (BMY +2.79%) posted an impressive quarterly earnings report Thursday morning. Investors clearly found muc...
Looking at the universe of stocks we cover at Dividend Channel , in trading on Tuesday, shares of Bristol Myers Squibb Co. (Symbol: BMY) were yielding above the...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.